Bio Business
Pet Meds Adapted from Human Therapies
Pet Meds Adapted from Human Therapies
Jenny Rood | Oct 1, 2016
Companies focused on developing treatments for dogs, cats, and horses are bringing a diverse array of products to the pet medicine market.
The Growth of Iowa Biotech
The Growth of Iowa Biotech
Jenny Rood | Aug 1, 2016
The state’s industry draws inspiration from medicine as well as agriculture.
Do Patents Promote or Stall Innovation?
Do Patents Promote or Stall Innovation?
Catherine Offord | Jun 1, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Banking on Blood Tests
Banking on Blood Tests
Jyoti Madhusoodanan | Apr 1, 2016
How close are liquid biopsies to replacing current diagnostics?
Desperately Seeking Shut-Eye
Desperately Seeking Shut-Eye
Anna Azvolinsky | Mar 1, 2016
New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.
Picking Up the Pace
Picking Up the Pace
Kate Yandell | Jan 1, 2016
FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.
Battling the Bulge
Battling the Bulge
Bob Grant | Nov 1, 2015
Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.
The Sounds of Silence
The Sounds of Silence
Jenny Rood | Sep 1, 2015
Science-based tinnitus therapeutics are finally coming into their own.
The Human Touch
The Human Touch
Kate Yandell | Aug 1, 2015
Can mice with humanlike tissues better model drug effects in people?
Clinical Matchmaker
Clinical Matchmaker
Kate Yandell | Jun 1, 2015
Enrolling the right patient population could be key to a successful clinical trial.